Potential US tariff a significant 'unknown' for business, says Dr Reddy's Lab CEO
Erez Israeli
, told ET.
'Don't know whether to call it a risk, but it is an unknown that could develop into a risk, and that is the tariff. We will know better as time will come about what it means and what we can do,' Israeli said over an earning call on Wednesday. 'It's not necessarily bad, it can also create an opportunity. It very much depends on what will be our relative situation to Chinese players or others.'
Explore courses from Top Institutes in
Please select course:
Select a Course Category
Technology
Leadership
Project Management
Healthcare
Management
Data Analytics
Data Science
others
Cybersecurity
Artificial Intelligence
Design Thinking
Degree
Product Management
Public Policy
Data Science
MCA
Finance
MBA
Others
healthcare
Operations Management
PGDM
CXO
Digital Marketing
Skills you'll gain:
Duration:
12 Weeks
MIT xPRO
CERT-MIT XPRO Building AI Prod India
Starts on
undefined
Get Details
The Hyderabad-based drug maker, which announced its first-quarter earnings, is betting big on generic version of
Novo Nordisk
's weight loss molecule semaglutide – that it plans to launch in 87 countries in 2026 - as a future growth driver.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
No annual fees for life
UnionBank Credit Card
Apply Now
Undo
'Our levers for the future consist of double-digit growth of the main business and then on top of it the success of semaglutide, which is very important to us, business development and our ability to optimise our resources,' Israeli said in response to ET's query.
'We are planning to launch semaglutide in 87 countries as the patent in the relevant country will allow us… We have some countries where there is no active patent as we speak, and in those we can launch. In the other countries, we need to wait for the patent expiration - for example Brazil or India - in which the patent goes on till March 2026. We are absolutely ready to launch on day 1 (post patent expiry) in each one of these markets,' he said.
Live Events
The company which is among the frontrunners for
GLP-1 drugs
is looking at launching 26 other products in the space over the next decade.
'We have 26 products (all peptides) in the GLP1 pipeline and will be launched over the next decade, according to the patent situation,' said Israeli.
On Wednesday, the company reported consolidated revenue for the first quarter at Rs 8,545 crore, an 11% increase from a year ago, mainly on account of contributions from its acquired consumer healthcare portfolio in nicotine replacement therapy (NRT) and sustained performance in branded markets. Net profit for the quarter stood at Rs 1,418 crore, up 2% y-o-y.
Israeli said an ongoing litigation over semaglutide with innovator company Novo Nordisk in India is not likely to hamper its planned product launches.
The company's global generics revenue in Q1FY26 stood at Rs 7,562 crore, a growth of 10% year-on-year.
However, revenue from North America–one of its key markets–declined 11% y-o-y to Rs 3,412 crore due to increased price erosion in select products, including lenalidomide. Its Europe revenue stood at Rs 1,274 crore, up 142% on account of NRT portfolio acquisition.
The company's India and emerging markets business grew 11% and 17% respectively.
The company's EBITDA margin for the first quarter stood at 26.7%.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
18 minutes ago
- NDTV
Woman Denied Boarding At Miami Airport Due To Cosmetic Procedure, Airline Responds
A woman claimed that she was denied boarding by Spirit Airlines at Miami International Airport Wednesday afternoon because of concerns over a cosmetic procedure she underwent days earlier. The Houston-based woman, named Shataria Banks, captured a video of her confrontation at the Spirit Airlines desk at the airport. "Even though y'all have my medical clearance, even though my doctor's-y'all are still restricting me to fly," Banks is heard saying in the video. While speaking to CBS News, she said she had arrived in Miami from Houston last week for a cosmetic procedure. She didn't reveal details about the procedure and preferred to keep it private. She came to the airport with documentation from her doctor clearing her to fly after several days of recovery. However, she was told that she would not be allowed to board when she tried to check in. "Well, we don't have it in writing-verbatim-from their spirit supervisor. It was just how I was treated on top of them just neglecting what my doctor said," Banks said, describing the exchange with Spirit employees. Here's what the airline said: "The safety and well-being of our Guests is our top priority. Our records show the agents followed our procedures and consulted with a designated on-call medical professional via our vendor MedLink to verify the Guest's fitness to travel," Spirit Airlines said in a statement. "The medical professional at MedLink was informed of the Guest's documentation and advised that the Guest was not fit to travel based on their condition at the time and in the interest of their safety. The Guest was ultimately issued a refund for the flight." As per the report, Banks said that she understands the need for safety; however, she called for clearer protocols. "I'm not saying that they can't deny their travelers and they're looking out for their safety, but have something in place, because everybody don't have money to waste for a new flight. I never want to fly with them, ever, ever," she said. The airline paid her the refund.
&w=3840&q=100)
Business Standard
18 minutes ago
- Business Standard
Startup founders can't be Batman, Superman, Mandrake combined: Shivakumar
What's changed in the past five to 10 years is the advent of consumer technology (tech), and today, consumers are using more digital services than physical ones, says Shivakumar premium Surajeet Das Gupta New Delhi Listen to This Article His just-released book, The CEO Mindset, focuses on leadership qualities in a complex world. Shiv Shivakumar, operating partner at Boston-based $500 billion private equity (PE) major Advent International — who has straddled various companies from Hindustan Lever to Aditya Birla group — talks to Surajeet Das Gupta about management challenges and business models. Edited excerpts: What is your assessment of the impact of artificial intelligence (AI) on Corporate India? AI will take out aggregator jobs — for example, the executive who prepares the minutes of board meetings is gone. Most of these roles lie in middle and lower management, but
The Hindu
18 minutes ago
- The Hindu
Urgent need for 'global approach' on AI regulation: U.N. tech chief
The world urgently needs to find a global approach on regulating artificial intelligence, the United Nations' top tech chief said this week, warning that fragmentation could deepen risks and inequalities. Doreen Bogdan-Martin, head of the UN's International Telecommunications Union (ITU) agency, told AFP she hoped that AI "can actually benefit humanity". But as concerns mount over the risks posed by the fast-moving technology -- including fears of mass job losses, the spread of deepfakes and disinformation, and society's fabric fraying -- she insisted that regulation was key. "There's an urgency to try to get... the right framework in place," she said, stressing the need for "a global approach". Her comments came after U.S. President Donald Trump this week unveiled an aggressive, low-regulation strategy aimed at ensuring the United States stays ahead of China on AI. Among more than 90 proposals, Trump's plan calls for sweeping deregulation, with the administration promising to "remove red tape and onerous regulation" that could hinder private sector AI development. Asked if she had concerns about an approach that urges less, not more, regulation of AI technologies, Bogdan-Martin refrained from commenting, saying she was "still trying to digest" the US plan. Lack of AI policies or strategies "I think there are different approaches," she said. "We have the EU approach. We have the Chinese approach. Now we're seeing the U.S. approach. I think what's needed is for those approaches to dialogue," she said. At the same time, she highlighted that "85% of countries don't yet have AI policies or strategies". A consistent theme among those strategies that do exist is the focus on innovation, capacity building and infrastructure investments, Bogdan-Martin said. "But where I think the debate still needs to happen at a global level is trying to figure out how much regulation, how little regulation, is needed," she said. Bogdan-Martin, who grew up in New Jersey and has spent most of her more than three-decade career at the ITU, insisted the Geneva-based telecoms agency that sets standards for new technologies was well-placed to help facilitate much-needed dialogue on the issue. "The need for a global approach I think is critical," she said, cautioning that "fragmented approaches will not help serve and reach all". As countries and companies sprint to cement their dominance in the booming sector, there are concerns that precautions could be thrown to the wind -- and that those who lose the race or do not have the capacity to participate will be left behind. Huge gap The ITU chief hailed "mind-blowing" advances within artificial intelligence, with the potential to improve everything from education to agriculture to health care -- but insisted the benefits must be shared. Without a concerted effort, there is a risk that AI will end up standing for "advancing inequalities", she warned, cautioning against deepening an already dire digital divide worldwide. "We have 2.6 billion people that have no access to the internet, which means they have no access to artificial intelligence", Bogdan-Martin pointed out. "We have to tackle those divides if we're actually going to have something that is beneficial to all of humanity." Bogdan-Martin, the first woman to serve as ITU secretary-general in the organisation's nearly 160-year history, also stressed the need to get more women into the digital space. "We have a huge gap," she said. "We definitely don't have enough women... in artificial intelligence." The 58-year-old mother of four said it was "a big honour" to be the first woman in her position, to be "breaking the glass ceiling (and) paving the path for future generations". But she acknowledged there was a lot of pressure, "not just to achieve, but to almost overachieve". Bogdan-Martin, who is being backed by the Trump administration to stand for re-election when her four-year mandate ends next year, said she was eager to stay on for a second term. "There is a lot to do."
